Can-Fite BioPharma (CANF) Net Margin (QoQ) (2015 - 2023)
Can-Fite BioPharma (CANF) Net Margin (QoQ) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Can-Fite BioPharma | 2.82 Mn | -8.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1.74 Mn |
| Sep 30, 2023 | 45,510.00 |
| Jun 30, 2023 | -10,561.00 |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | -2.00 Mn |
| Sep 30, 2022 | -24,657.00 |
| Jun 30, 2022 | 17,261.00 |
| Mar 31, 2022 | 210,092.00 |
| Dec 31, 2021 | 212,770.00 |
| Sep 30, 2021 | -820,594.00 |
| Jun 30, 2021 | 405,892.00 |
| Mar 31, 2021 | 162,975.00 |
| Dec 31, 2020 | 680,512.00 |
| Sep 30, 2020 | -1.66 Mn |
| Jun 30, 2020 | 905,911.00 |
| Mar 31, 2020 | 846,645.00 |
| Dec 31, 2019 | -1.09 Mn |
| Sep 30, 2019 | 183,739.00 |
| Jun 30, 2019 | -210,724.00 |
| Mar 31, 2019 | 388,665.00 |